180
Views
11
CrossRef citations to date
0
Altmetric
Technical Brief

Decisional procalcitonin thresholds are not adapted toelderly patients admitted to the emergency room

, , , , , & show all
Pages 477-481 | Received 27 Feb 2012, Accepted 13 Apr 2012, Published online: 21 May 2012

References

  • Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, Riou B, Bernard M, Hausfater P. (2008). Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 36:1147–1154.
  • Boussekey N, Leroy O, Georges H, Devos P, d’Escrivan T, Guery B. (2005). Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit. Infection 33:257–263.
  • Caterino JM, Scheatzle MD, Forbes ML, D’Antonio JA. (2004). Bacteremic elder emergency department patients: procalcitonin and white count. Acad Emerg Med 11:393–396.
  • Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B. (2004). Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600–607.
  • Claessens YE, Dhainaut JF. (2007). Diagnosis and treatment of severe sepsis. Crit Care 11 Suppl 5:S2.
  • Cohen HJ, Harris T, Pieper CF. (2003). Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 114:180–187.
  • Dahaba AA, Rehak PH, List WF. (2003). Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 29:579–583.
  • Guinard-Barbier S, Grabar S, Chenevier-Gobeaux C, Quinquis L, Schmidt J, Kierzek G, Guérin S, Hausfater P, Bernot B, Brun P, Gayet A, Casalino E, Andreotti C, Renaud B, Claessens YE. (2011). Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis? Biomarkers 16:355–363.
  • Herget-Rosenthal S, Klein T, Marggraf G, Hirsch T, Jakob HG, Philipp T, Kribben A. (2005). Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 61:180–186.
  • Htwe TH, Mushtaq A, Robinson SB, Rosher RB, Khardori N. (2007). Infection in the elderly. Infect Dis Clin North Am 21:711–43, ix.
  • Joram N, Boscher C, Denizot S, Loubersac V, Winer N, Roze JC, Gras-Le Guen C. (2006). Umbilical cord blood procalcitonin and C reactive protein concentrations as markers for early diagnosis of very early onset neonatal infection. Arch Dis Child Fetal Neonatal Ed 91:F65–F66.
  • Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. (2007). Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772.
  • Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Müller B. (2005). Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37–R45.
  • Morgenthaler NG, Struck J, Fischer-Schulz C, Seidel-Mueller E, Beier W, Bergmann A. (2002). Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clin Lab 48:263–270.
  • Müller B, Becker KL, Schächinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R. (2000). Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983.
  • Musso CG, Oreopoulos DG. (2011). Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol 119 Suppl 1:p1–p5.
  • Opal SM, Esmon C. (2003). Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 7:23–38.
  • Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B; ProHOSP Study Group. (2009). Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302:1059–1066.
  • Schuetz P, Albrich W, Mueller B. (2011). Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 9:107.
  • Singh T, Newman AB. (2011). Inflammatory markers in population studies of aging. Ageing Res Rev 10:319–329.
  • Stevens LA, Viswanathan G, Weiner DE. (2010). Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis 17:293–301.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.